Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: ROBERT H RICHMOND who wrote (1295)	1/17/1998 6:30:00 PM
From: David S.	Respond to of 2205

As you know, I have thought that market potential for ATIS is overstated. Nevertheless, having attended Geron's presentation and the H&Q conference last week, I'd like to say that Geron's technology or offshoots won't be a threat to ATIS, ORG, or similar companies for the forseeable future. Geron has opened a very wide door and because they have, people will speculate that telomerase will affect everything from dandruff to the price of tea in China. A bit of sanity is needed.